BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22483464)

  • 1. Gene polymorphisms are associated with posttransplantation diabetes mellitus among Taiwanese renal transplant recipients.
    Weng SC; Shu KH; Tarng DC; Wu MJ; Chen CH; Yu TM; Chuang YW; Huang ST; Cheng CH
    Transplant Proc; 2012 Apr; 44(3):667-71. PubMed ID: 22483464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Kim CH; Han SJ; Chun SW; Hur KY; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes; 2008 Apr; 57(4):1043-7. PubMed ID: 18162509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism.
    Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP
    Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Hur KY; Han SJ; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes Care; 2008 Jan; 31(1):63-8. PubMed ID: 17934151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin gene polymorphisms are associated with posttransplantation diabetes mellitus in Chinese renal allograft recipients.
    Yu AR; Xin HW; Wu XC; Fan X; Liu HM; Li G; Bai Y
    Transplant Proc; 2011 Jun; 43(5):1607-11. PubMed ID: 21693241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus.
    Chang HR; Yang SF; Tsai JP; Hsieh MC; Wu SW; Tsai HC; Hung TW; Huang JH; Lian JD
    Clin Chim Acta; 2011 Jan; 412(3-4):322-6. PubMed ID: 21070757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy.
    Viklický O; Hubácek JA; Kvasnicka J; Matl I; Voska L; Skibová J; Teplan V; Vítko S
    Clin Biochem; 2004 Oct; 37(10):919-24. PubMed ID: 15369724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 is a potential risk factor for posttransplantation diabetes mellitus in autosomal dominant polycystic kidney disease patients.
    Pietrzak-Nowacka M; Safranow K; Nowosiad M; Dębska-Ślizień A; Dziewanowski K; Głyda M; Jankowska M; Rutkowski B; Ciechanowski K
    Transplant Proc; 2010 Nov; 42(9):3465-70. PubMed ID: 21094798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of tumor necrosis factor-β, interleukin-10, and interleukin-1 gene cluster polymorphism with susceptibility to pneumonia in kidney transplant recipients.
    Wan QQ; Li JL; Ye QF; Zhou JD
    Transplant Proc; 2013; 45(6):2211-4. PubMed ID: 23953530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association of interleukin-1β (-511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients.
    Wan QQ; Ye QF; Ma Y; Zhou JD
    Transplant Proc; 2012 Dec; 44(10):3026-8. PubMed ID: 23195019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients.
    Yildiz A; Tütüncü Y; Yazici H; Akkaya V; Kayacan SM; Sever MS; Carin M; Karşidağ K
    Transplantation; 2002 Oct; 74(8):1109-13. PubMed ID: 12438955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.
    Kang ES; Kim MS; Kim CH; Nam CM; Han SJ; Hur KY; Ahn CW; Cha BS; Kim SI; Lee HC; Kim YS
    Transplantation; 2009 Sep; 88(5):693-8. PubMed ID: 19741467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.